These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27113954)

  • 41. Weight Loss During Atomoxetine Add-on to Clozapine-Responsive Schizophrenia.
    Naguy A; Alamiri B; Khraibut B
    Am J Ther; 2018; 25(6):e774-e775. PubMed ID: 29782344
    [No Abstract]   [Full Text] [Related]  

  • 42. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
    Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF
    Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacological strategies for clozapine-induced hypersalivation: treatment with botulinum toxin B in one patient and review of the literature].
    Kahl KG; Trillenberg P; Kordon A; Lencer R; Klein C; Hagenah J
    Nervenarzt; 2005 Feb; 76(2):205-8. PubMed ID: 15448913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
    Blissit KT; Tillery E; Latham C; Pacheco-Perez J
    Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea.
    Leung JG; Puri NV; Jacobson MJ
    Ann Pharmacother; 2011 Sep; 45(9):e45. PubMed ID: 21852588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
    Croissant B; Hermann D; Olbrich R
    Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clozapine-induced hypersalivation.
    Davydov L; Botts SR
    Ann Pharmacother; 2000 May; 34(5):662-5. PubMed ID: 10852096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
    Kreinin A; Novitski D; Weizman A
    Int Clin Psychopharmacol; 2006 Mar; 21(2):99-103. PubMed ID: 16421461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphisms in
    Puolakka H; Solismaa A; Lyytikäinen LP; Viikki M; Seppälä N; Mononen N; Lehtimäki T; Kampman O
    Acta Neuropsychiatr; 2024 Aug; 36(4):218-223. PubMed ID: 38634369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histidine Metabolic Pathway Contributes to Clozapine-Induced Sialorrhea Based on Nontargeted Metabolomics.
    Zhang K; Wu S; Wang Y; Zhou Y; Guo J; Xiao A; Ye J; Wu B; Li S; Zhu F; Li Z; Yu L
    Neuropsychobiology; 2023; 82(5):271-286. PubMed ID: 37640020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological interventions for clozapine-induced hypersalivation.
    Syed Sheriff RJ; Au K; Cahill C; Duggan L; He Y; Udu V; Xia J
    Schizophr Bull; 2008 Jul; 34(4):611-2. PubMed ID: 18495644
    [No Abstract]   [Full Text] [Related]  

  • 53. Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial.
    Segev A; Evans A; Hodsoll J; Whiskey E; Sheriff RS; Shergill S; MacCabe JH
    Int Clin Psychopharmacol; 2019 Mar; 34(2):101-107. PubMed ID: 30614850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea.
    Verma R; Anand KS
    Psychopharmacology (Berl); 2018 Jan; 235(1):369-371. PubMed ID: 29196826
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials.
    Fornaro M; Caiazza C; Solini N; De Prisco M; Billeci M; Vannini M; Shorr R; Caiolo S; Lussignoli M; Siskind D; Pigato G; Barone A; Sambataro F; de Bartolomeis A; Correll CU; Solmi M
    Mol Psychiatry; 2023 Sep; 28(9):3648-3660. PubMed ID: 37821573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series.
    Freudenreich O; Beebe M; Goff DC
    J Clin Psychopharmacol; 2004 Feb; 24(1):98-100. PubMed ID: 14709958
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient: A Case Report.
    Akça D; Güneş A; Karaçetin G
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):606-607. PubMed ID: 36251377
    [No Abstract]   [Full Text] [Related]  

  • 58. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
    Man WH; Colen-de Koning JC; Schulte PF; Cahn W; van Haelst IM; Doodeman HJ; Egberts TC; Heerdink ER; Wilting I
    J Clin Psychopharmacol; 2017 Apr; 37(2):155-161. PubMed ID: 28129312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aspiration pneumonia possibly secondary to clozapine-induced sialorrhea.
    Hinkes R; Quesada TV; Currier MB; Gonzalez-Blanco M
    J Clin Psychopharmacol; 1996 Dec; 16(6):462-3. PubMed ID: 8959476
    [No Abstract]   [Full Text] [Related]  

  • 60. Trihexyphenidyl as a possible therapeutic option in clozapine-induced nocturnal enuresis.
    Poyurovsky M; Modai I; Weizman A
    Int Clin Psychopharmacol; 1996 Mar; 11(1):61-3. PubMed ID: 8732317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.